Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

The rapidly spreading Omicron variant is highly resistant to vaccines, convalescent sera, and neutralizing antibodies (nAbs), highlighting the urgent need for potent therapeutic nAbs. Here, a panel of human nAbs from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) convalescent patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Siling, Sun, Hui, Zhang, Yali, Yuan, Lunzhi, Wang, Yizhen, Zhang, Tianying, Wang, Shaojuan, Zhang, Jinlei, Yu, Hai, Xiong, Hualong, Tang, Zimin, Liu, Liqin, Huang, Yang, Chen, Xiuting, Li, Tingting, Ying, Dong, Liu, Chang, Chen, Zihao, Yuan, Quan, Zhang, Jun, Cheng, Tong, Li, Shaowei, Guan, Yi, Zheng, Qingbing, Zheng, Zizheng, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080080/
https://www.ncbi.nlm.nih.gov/pubmed/35594869
http://dx.doi.org/10.1016/j.celrep.2022.110862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080080/
https://www.ncbi.nlm.nih.gov/pubmed/35594869
http://dx.doi.org/10.1016/j.celrep.2022.110862

Ejemplares similares